Hovione's $35M CDC Flex line links spray drying to tablets, designed to eliminate scale-up under FDA Q13 guidance.
|Articles|April 1, 2011
The new HygroLog HL-20/21 series
The new HygroLog HL20/21 series is the latest development of data loggers for relative humidity, temperature, dew point and frost point.
Advertisement
The new HygroLog HL20/21 series is the latest development of data loggers for relative humidity, temperature, dew point and frost point. These loggers give you the accuracy and reliability to measure and record your essential data whether it be in pharmaceutical clean rooms, storage facilities, manufacturing floors, buildings, museums or any other critical area.
Highlights
- Highest accuracy at 0.8 %rh and 0.2 ˚C
- Outstanding long-term stability
- 20'000 data point memory with date & time stamps
- Programmable Alarm limits
- Programmable recording intervals
- Psychrometric Calculations of Dew Point and Frost Point
- FDA 21 CFR Part 11 / GAMP 4 compliant
- USB interface
- Long Battery Life
Technical specifications:
- Measurement accuracy at 23 °C: ±0.8 %rh / ±0.2 °C
- Operating limits: 0...100 %rh / -10…60 °C, with LCD: 0….50°C
- Recording capacity : HL-20; 20000 value pairs (rh+°C) / HL-21; 20000 values (°C)
You can find further detailed information about the new HygroLog HL-20/21 and all about humidity and temperature measurement at ROTRONIC at
Advertisement
Related to this article
This week on PharmTech, Merck diversified its pipeline, USP emphasizes supply chain security, AI systems are examined, and speakers preview their presentations at CPHI Milan and AAPS PharmSci 360.
Capsugel's Bram Baert and Sandrine Picco argue that chasing zero nitrite in pharmaceutical excipients is often impractical and costly. They recommend setting scientifically justified, risk-based limits and consistently staying below them.
Ron Scarboro, Azurity Pharmaceuticals, claims drug reformulation that removes patient barriers must preserve efficacy, urging early cross-functional team alignment.
PharmTech AI Pulse Check episode 2 covers AI data governance, API-gated journals, watermarking limits, and why attribution beats detection in GxP.
The FDA opened an expedited IND pilot, tightened scrutiny of foreign trial data, and finalized a rule recognizing non-animal testing methods. In Europe, the EMA advanced pharmaceutical legislation reform, restricted 2 legacy products, and opened an injectable-iron safety review.
Novartis licenses Abogen's mRNA-encoded T-cell engager for autoimmune disease, raising scale-up questions for mRNA-lipid nanoparticle manufacturing.
Pharma manufacturing spent 90 years learning that producing correct outputs isn't the same as catching your own errors. AI has only learned the first.
Advertisement
Advertisement